Goldman Sachs Group Inc Prime Medicine, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 220,144 shares of PRME stock, worth $737,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares
220,144
Previous 79,367 177.37%
Holding current value
$737,482
Previous $407,000 109.09%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.41 - $6.7 $480,049 - $943,205
140,777 Added 177.37%
220,144 $851,000
Q2 2024

Aug 13, 2024
BUY
$4.3 - $8.03 $177,104 - $330,731
41,187 Added 107.88%
79,367 $407,000
Q1 2024

May 15, 2024
SELL
$6.35 - $9.39 $82,353 - $121,778
-12,969 Reduced 25.36%
38,180 $267,000
Q4 2023

Feb 13, 2024
SELL
$5.59 - $9.55 $43,389 - $74,127
-7,762 Reduced 13.18%
51,149 $453,000
Q3 2023

May 14, 2024
BUY
$9.5 - $15.07 $73,739 - $116,973
7,762 Added 15.18%
58,911 $562,000
Q3 2023

Nov 14, 2023
BUY
$9.5 - $15.07 $559,654 - $887,788
58,911 New
58,911 $562,000

Others Institutions Holding PRME

# of Institutions
124
Shares Held
64.7M
Call Options Held
324K
Put Options Held
64.4K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email